The action of MBL-associated serine protease 1 (MASP1) on factor XIII and fibrinogen

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1784, Issue 9, 2008, Pages 1294-1300

  Krarup, Anders ^a   Gulla, Krishana C ^a,b   Gál, Péter ^c   Hajela, Krishnan ^b,d   Sim, Robert B ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b DEVI AHILYA UNIVERSITY   (India)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^d UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Coagulation system; Complement; Factor XIII; Fibrinogen; Lectin pathway; MASP

Indexed keywords

BINDING PROTEIN; BLOOD CLOTTING FACTOR 13; FIBRINOGEN; FIBRINOPEPTIDE B; FICOLIN; MANNAN BINDING LECTIN SERINE PROTEASE 1; THROMBIN; UNCLASSIFIED DRUG; FIBRINOPEPTIDE A; MANNAN BINDING LECTIN ASSOCIATED SERINE PROTEINASE; MASP1 PROTEIN, HUMAN; PEPTIDE FRAGMENT; PROTEIN SUBUNIT; RECOMBINANT PROTEIN;

ARTICLE; BETA CHAIN; BLOOD CLOT; CATALYSIS; COMPLEMENT SYSTEM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME SPECIFICITY; ENZYME SUBSTRATE; FIBRIN CLOT; INFECTION PREVENTION; INNATE IMMUNITY; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN METABOLISM; AMINO ACID SEQUENCE; BINDING SITE; CHEMISTRY; GENETICS; HUMAN; IN VITRO STUDY; METABOLISM; MOLECULAR GENETICS;

AMINO ACID SEQUENCE; BINDING SITES; FACTOR XIII; FIBRINOGEN; FIBRINOPEPTIDE A; FIBRINOPEPTIDE B; HUMANS; MANNOSE-BINDING PROTEIN-ASSOCIATED SERINE PROTEASES; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROTEIN SUBUNITS; RECOMBINANT PROTEINS; SUBSTRATE SPECIFICITY; THROMBIN;

EID: 53149096593     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2008.03.020     Document Type: Article

References (35)

1. K.R. Mayilyan, Y.H. Kang, A.W. Dodds, R.B. Sim, in: H. Heine (Ed.), Innate Immunity of Plants, Animals and Humans, Springer-Verlag, Berlin, 2008, pp. 219-236.
2. D.R. Burton, J. Boyd, A.D. Brampton, S.B. Easterbrook-Smith, E.J. Emanuel, J. Novotny, T.W. Rademacher, M.R. van Schravendijk, M.J. Sternberg, R.A. Dwek, The Clq receptor site on immunoglobulin G, Nature 288 (1980) 338-344.
3. R.B. Sim, R. Malhotra, Interactions of carbohydrates and lectins with complement, Biochem. Soc. Trans. 22 (1994) 106-111.
4. A.W. Dodds, R.B. Sim, R.R. Porter, M.A. Kerr, Activation of the first component of human complement (C1) by antibody-antigen aggregates, Biochem. J. 175 (1978) 383-390.
5. K. Ikeda, T. Sannoh, N. Kawasaki, T. Kawasaki, I. Yamashina, Serum lectin with known structure activates complement through the classical pathway, J. Biol. Chem. 262 (1987) 7451-7454.
6. M. Matsushita, A. Takahashi, H. Hatsuse, M. Kawakami, T. Fujita, Human mannose-binding protein is identical to a component of Ra-reactive factor, Biochem. Biophys. Res. Commun. 183 (1992) 645-651.
7. S. Thiel, T. Vorup-Jensen, C.M. Stover, W. Schwaeble, S.B. Laursen, K. Poulsen, A.C. Willis, P. Eggleton, S. Hansen, U. Holmskov, K.B. Reid, J.C. Jensenius, A second serine protease associated with mannan-binding lectin that activates complement, Nature 386 (1997) 506-510.
8. M.R. Dahl, S. Thiel, M. Matsushita, T. Fujita, A.C. Willis, T. Christensen, T. Vorup-Jensen, J.C. Jensenius, MASP-3 and its association with distinct complexes of the mannan-binding lectin complement activation pathway, Immunity 15 (2001) 127-135.
9. C.M. Stover, S. Thiel, M. Thelen, N.J. Lynch, T. Vorup-Jensen, J.C. Jensenius, W.J. Schwaeble, Two constituents of the initiation complex of the mannan-binding lectin activation pathway of complement are encoded by a single structural gene, J. Immunol. 162 (1999) 3481-3490.
10. M. Matsushita, Y. Endo, T. Fujita, Cutting edge: complement-activating complex of ficolin and mannose-binding lectin-associated serine protease, J. Immunol. 164 (2000) 2281-2284.
11. M. Matsushita, M. Kuraya, N. Hamasaki, M. Tsujimura, H. Shiraki, T. Fujita, Activation of the lectin complement pathway by H-ficolin (Hakata antigen), J. Immunol. 168 (2002) 3502-3506.
12. Y. Liu, Y. Endo, D. Iwaki, M. Nakata, M. Matsushita, I. Wada, K. Inoue, M. Munakata, T. Fujita, Human m-ficolin is a secretory protein that activates the lectin complement pathway, J. Immunol. 175 (2005) 3150-3156.
13. A. Krarup, R. Wallis, J.S. Presanis, P. Gal, R.B. Sim, Simultaneous activation of complement and coagulation by MBL-associated serine protease 2, PLoS ONE 2 (2007) e623.
14. M. Matsushita, S. Thiel, J.C. Jensenius, I. Terai, T. Fujita, Proteolytic activities of two types of mannose-binding lectin-associated serine protease, J. Immunol. 165 (2000) 2637-2642.
15. M. Matsushita, T. Fujita, Cleavage of the third component of complement (C3) by mannose-binding protein-associated serine protease (MASP) with subsequent complement activation, Immunobiology 194 (1995) 443-448.
16. K. Hajela, M. Kojima, G. Ambrus, K.H. Wong, B.E. Moffatt, J. Ferluga, S. Hajela, P. Gal, R.B. Sim, The biological functions of MBL-associated serine proteases (MASPs), Immunobiology 205 (2002) 467-475.
17. G. Ambrus, P. Gal, M. Kojima, K. Szilagyi, J. Balczer, J. Antal, L. Graf, A. Laich, B.E. Moffatt, W. Schwaeble, R.B. Sim, P. Zavodszky, Natural substrates and inhibitors of mannan-binding lectin-associated serine protease-1 and -2: a study on recombinant catalytic fragments, J. Immunol. 170 (2003) 1374-1382.
18. M. Moller-Kristensen, S. Thiel, A. Sjoholm, M. Matsushita, J.C. Jensenius, Cooperation between MASP-1 and MASP-2 in the generation of C3 convertase through the MBL pathway, Int. Immunol. 19 (2007) 141-149.
19. J.S. Presanis, K. Hajela, G. Ambrus, P. Gal, R.B. Sim, Differential substrate and inhibitor profiles for human MASP-1 and MASP-2, Mol. Immunol. 40 (2004) 921-929.
20. Z. Yang, J.M. Kollman, L. Pandi, R.F. Doolittle, Crystal structure of native chicken fibrinogen at 2.7 A resolution, Biochemistry 40 (2001) 12515-12523.
21. R.F. Doolittle, Fibrinogen and fibrin, Annu. Rev. Biochem. 53 (1984) 195-229.
22. Z. Bereczky, E. Katona, L. Muszbek, Fibrin stabilization (factor XIII), fibrin structure and thrombosis, Pathophysiol. Haemost. Thromb. 33 (2003) 430-437.
23. C. Esposito, I. Caputo, Mammalian transglutaminases. Identification of substrates as a key to physiological function and physiopathological relevance, Febs. J. 272 (2005) 615-631.
24. U.K. Laemmli, Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature 227 (1970) 680-685.
25. G. Fairbanks, T.L. Steck, D.F. Wallach, Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane, Biochemistry 10 (1971) 2606-2617.
26. P. Matsudaira, Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes, J. Biol. Chem. 262 (1987) 10035-10038.
27. S. Zundel, S. Cseh, M. Lacroix, M.R. Dahl, M. Matsushita, J.P. Andrieu, W.J. Schwaeble, J.C. Jensenius, T. Fujita, G.J. Arlaud, N.M. Thielens, Characterization of recombinant mannan-binding lectin-associated serine protease (MASP)-3 suggests an activation mechanism different from that of MASP-1 and MASP-2, J. Immunol. 172 (2004) 4342-4350.
28. T. Osaki, S. Kawabata, Structure and function of coagulogen, a clottable protein in horseshoe crabs, Cell Mol. Life Sci. 61 (2004) 1257-1265.
29. D.H. Ahrenholz, R.L. Simmons, Fibrin in peritonitis. I. Beneficial and adverse effects of fibrin in experimental E. coli peritonitis, Surgery 88 (1980) 41-47.
30. I.K. Mullarky, F.M. Szaba, K.N. Berggren, M.A. Parent, L.W. Kummer, W. Chen, L.L. Johnson, S.T. Smiley, Infection-stimulated fibrin deposition controls hemorrhage and limits hepatic bacterial growth during listeriosis, Infect. Immun. 73 (2005) 3888-3895.
31. M.J. Flick, X. Du, J.L. Degen, Fibrin(ogen)-alpha M beta 2 interactions regulate leukocyte function and innate immunity in vivo, Exp. Biol. Med. (Maywood) 229 (2004) 1105-1110.
32. A.B. Kay, D.S. Pepper, R. McKenzie, The identification of fibrinopeptide B as a chemotactic agent derived from human fibrinogen, Br. J. Haematol. 27 (1974) 669-677.
33. R.M. Senior, W.F. Skogen, G.L. Griffin, G.D. Wilner, Effects of fibrinogen derivatives upon the inflammatory response. Studies with human fibrinopeptide, B. J. Clin. Invest. 77 (1986) 1014-1019.
34. D.L. Richardson, D.S. Pepper, A.B. Kay, Chemotaxis for human monocytes by fibrinogen-derived peptides, Br. J. Haematol. 32 (1976) 507-513.
35. M. Huber-Lang, J.V. Sarma, F.S. Zetoune, D. Rittirsch, T.A. Neff, S.R. McGuire, J.D. Lambris, R.L. Warner, M.A. Flierl, L.M. Hoesel, F. Gebhard, J.G. Younger, S.M. Drouin, R.A. Wetsel, P.A. Ward, Generation of C5a in the absence of C3: a new complement activation pathway, Nat. Med. 12 (2006) 682-687.